Next Week: Office of New Drug (OND) Research: Seeking Collaborators; Funding Opportunities Available - Nov. 6, 2020

Office of New Drug (OND) Research: Seeking Collaborators; Funding Opportunities Available Friday, November 6, 2020 | 1:00 p.m. - 2:30 p.m. Eastern This webinar is FREE. REGISTER Participants will be able to describe how FDA's Office of New Drugs (OND) uses regulatory science research to address knowledge gaps that slow down or prevent new drug development. They will gain familiarity of research opportunities available to currently enrolled and recently graduated college students through the OND ORISE fellowship program. The learner will also become aware of two OND extramural research programs that have funding opportunities available for external collaborators. TOPICS COVERED Overview of OND's regulatory science research portfolio. Examples of how the Office uses funding to address knowledge gaps that prevent or slow down drug development. Overview of FDA's Oak Ridge Institute for Science and Education (ORISE) Fellowship Program. Examples of opportunities, requirements for applicants, tips for how to find projects and apply for fellowships. Overview of OND's Combatting Antibiotic-Resistant Bacteria (CARB) Program. Overview of OND's 21st Century Cures Drug Development Tools Grant Program. Description of opportunities for collaborating, types of projects being solicited, and how to apply for funding. Location of websites where priority lists and funding opportunities are posted. CONTINUING EDUCATION Real-time attendance is required for the certificate of attendance. Certificates are only available during the three weeks post-event. This course: has been pre-approved by RAPS as eligible for up to 2 credits towards a participant's RAC recertification upon full completion. has been pre-approved by SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate's clinical research therapeutic area. has been pre-approved by SQA as eligible for 0.25 non-GCP or non-GLP units for every 1 hour of instructional time towards a participant's RQAP re-registration. has been approved by ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material. The Small Business and Industry Assistance program in the Center for Drug Evaluation and Research (CDER SBIA) provides guidance, education and regular updates for regulated industry. Register for Upcoming Training Subscribe to CDER SBIA Email Updates View Learning Library on YouTube Follow on LinkedIn CDERSBIA@fda.hhs.gov | 1-866-405-5367 | (301) 796-6707 This is an automated message delivery system. Replying to this message will not reach the CDER SBIA staff. If you have comments or questions, please contact us. Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA